Market Tracker

08/30 3:01pm ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

95.70
BATS BZX Real-Time Price
As of 3:01pm ET
 -1.24 / -1.28%
Today’s Change
75.90
Today|||52-Week Range
136.97
-23.95%
Year-to-Date
5 Toxic Stocks to Steer Clear Of Before It's Too Late
9:01am / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data
Aug 17 / Zacks.com - Paid Partner Content
Stock Market News for August 25, 2016
Aug 25 / Zacks.com - Paid Partner Content
Vertex (VRTX) To Stop VX-661-Ivacaftor Study, Stock Down
Aug 16 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen
Aug 18 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close96.94
Today’s open97.00
Day’s range95.58 - 97.37
Volume28,412
Average volume (3 months)1,539,713
Market cap$24.0B
Dividend yield--
Data as of 3:01pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)+26.43%
Earnings growth (this year)+190.86%
Earnings growth (next 5 years)+46.00%
Revenue growth (last year)+77.86%
P/E ratioNM
Price/Sales29.41
Price/Book25.40

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-0.41-0.95%
ZTSZoetis Inc-0.18-0.35%
BAXBaxter International...-0.53-1.12%
ALXNAlexion Pharmaceutic...-0.37-0.29%
Data as of 3:01pm ET, 08/30/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.28
Annual revenue (last year)$1.0B
Annual profit (last year)-$556.3M
Net profit margin-53.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts